Major Shareholders Increase Stakes in ENN Energy, SSY Group, and CStone Pharma

Major shareholders of several prominent Hong Kong-listed companies have increased their stakes, signaling confidence from key insiders and corporate entities, according to shareholder disclosure filings dated September 18, 2026.

Details of the Stake Increases

The disclosures, reported by Zhitong Finance, detail several notable changes in long positions for major shareholders across the energy and pharmaceutical sectors:

• ENN Energy (02688): The long positions held by Chairman Wang Yusuo and by Zhao Baoju each increased to 35.08% from a previous 35.05%.
• SSY Group (02005): Chairman Qu Jiguang's stake rose to 43.21% from 43.16%, with his share count increasing from 1.274 billion to 1.275 billion. Separately, China Pharmaceutical Company Limited increased its holding to 31.18% from 31.13%.
• CStone Pharmaceuticals-B (02616): Yang Jianxin's stake grew to 5.29% from 5.28%, representing an increase from 84.28 million to 84.42 million shares.
• Gushengtang (02273): Tu Zhiliang increased his shareholding by 10,000 shares to 82.17 million, with his reported stake holding steady at 35.06%.

Market Significance

An increase in holdings by major shareholders, particularly founders, executives, or related corporations, is often interpreted by the market as a positive signal. Such transactions can suggest that those with the most intimate knowledge of a company's operations and prospects believe its stock is undervalued or poised for future growth.

Ad

These disclosures are a mandatory requirement under Hong Kong's Securities and Futures Ordinance (SFO) when a substantial shareholder's interest changes and crosses certain percentage thresholds. This regulation ensures market transparency and allows all investors to monitor the activity of significant stakeholders.

Background on the Companies

The companies involved represent a cross-section of key industries. ENN Energy is a major clean energy distributor in China. SSY Group is a large-scale pharmaceutical manufacturer specializing in intravenous solutions.

CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies. Gushengtang is a leading provider of Traditional Chinese Medicine (TCM) healthcare services through its network of clinics.